Literature DB >> 11096574

Variceal Bleeding.

.   

Abstract

Cirrhotic patients should receive an endoscopy. Those with medium to large varices identified by endoscopy should receive beta-blocker therapy. The initial episode of variceal bleeding should be managed with endoscopic therapy to control the acute bleeding and concurrent infusion of octreotide. Portal hypertension and liver disease should be fully evaluated after such an episode, and patients should be started on first-line treatment (endoscopic therapy and pharmacologic therapy) to reduce the risk of further bleeding. Patients who bleed again after first-line therapy, and those with persistent risk factors whose varices are not obliterated by first-line treatment should be considered for second-line treatment, which is variceal decompression with transjugular intrahepatic portosystemic shunt (TIPS) or surgical shunt. For patients with end-stage liver disease, liver transplantation may be the most appropriate treatment option. The management of variceal bleeding leading up to transplantation depends on the severity of the bleeding and available expertise. Minimal therapy to bridge the patient to transplantation is the goal. Devascularization procedures are reserved for patients who are not candidates for decompression because of venous thrombosis.

Entities:  

Year:  1999        PMID: 11096574     DOI: 10.1007/s11938-999-0020-7

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  17 in total

Review 1.  Pharmacological treatment of portal hypertension: present and future.

Authors:  D Lebrec
Journal:  J Hepatol       Date:  1998-05       Impact factor: 25.083

2.  Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension: the good, the bad, the ugly.

Authors:  R J Groszmann
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

Review 3.  Portal hypertension.

Authors:  J M Henderson; D S Barnes; M A Geisinger
Journal:  Curr Probl Surg       Date:  1998-05       Impact factor: 1.909

4.  TIPS: the long and short of it.

Authors:  N D Grace
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

5.  The treatment of portal hypertension: a meta-analytic review.

Authors:  G D'Amico; L Pagliaro; J Bosch
Journal:  Hepatology       Date:  1995-07       Impact factor: 17.425

6.  Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver.

Authors:  M J Orloff; M S Orloff; S L Orloff; M Rambotti; B Girard
Journal:  J Am Coll Surg       Date:  1995-03       Impact factor: 6.113

7.  Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study.

Authors: 
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

8.  Role of liver transplantation in management of esophageal variceal hemorrhage.

Authors:  B Ringe; H Lang; G Tusch; R Pichlmayr
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

9.  Portal pressure, presence of gastroesophageal varices and variceal bleeding.

Authors:  G Garcia-Tsao; R J Groszmann; R L Fisher; H O Conn; C E Atterbury; M Glickman
Journal:  Hepatology       Date:  1985 May-Jun       Impact factor: 17.425

10.  A systematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives.

Authors:  I J Sarfeh; E B Rypins; G R Mason
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.